
Keywords: adverse effects; hydroxychloroquine; lupus erythematosus; monitoring; recommendations; retinopathy screening; whole blood levels; ABW; actual body weight; AE; adverse effect; CLE; cutaneous lupus erythematosus; G6PD; glucose-6-phosphate dehydrogenase; HCQ